Vice President, Late-Stage Clinical Development

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.

4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products. We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.  

Company Differentiators: 

•    Fully integrated clinical-phase company with internal manufacturing
•    Demonstrated ability to move rapidly from idea to IND
•    Five candidate products in the clinic and two declared pre-clinical programs
•    Robust technology and IP foundation, including our TVE and manufacturing platforms
•    Initial product safety and efficacy data substantiates the value of our platforms
•    Opportunities to expand to other indications and modalities within genetic medicine

GENERAL SUMMARY: 

Reporting to the Sr. Vice President, Ophthalmology Therapeutic Area Head the VP Late Stage Ophthalmology provides strategic and operational leadership for the global development of ophthalmic genetic medicines in Late Stage Drug Development Phase.

We seek an experienced physician to play a critical role in the build out and leading of the late stage Clinical Development Organization at 4DMT as we spearhead the introduction of the first intravitreally delivered genetic medicines for the treatment of the most common causes of irreversible blindness. The successful candidate will lead the late stage clinical development strategy and execution and clinical trial in late stage. A candidate for this role should also feel confident to attract and develop talent in their part of the organization as indications and the trial portfolio grow. The VP, Clinical Development will be the primary point person for medical oversight of clinical studies with responsibilities to include clinical trial design, protocol development, medical monitoring, review and interpretation of clinical trial data, drafting key clinical documents such as protocol, CSR, briefing package, IND, NDA, BLA, etc. This role will be responsible for timely execution of deliverables in close collaboration with relevant internal and external partners.

RESPONSIBILITIES: 

• Lead the development of the Late Stage Ophthalmology Therapeutic Area Strategy in collaboration with cross functional partners (including but not limited to Commercial, CMC, Regulatory, and Early Research)
• Implement Ophthalmology TA Strategy through phase 3 and ph 4 studies in the clinical development plans
• Lead and manage a team of physicians and clinical scientists to design and execute the late stage clinical trials across the designated ophthalmic diseases in alignment with the Ophthalmology TA strategy.
• Provide Clinical Scientific Leadership to the study teams
• Provide medical leadership for cross-functional internal workstreams including pharmacovigilance, biostatistics, clinical operations, regulatory affairs, etc.
• Collaborate as appropriate with early research and other functions as appropriate to identify potential new targets for development in the treatment of ophthalmic diseases, which may include and not limited to due diligences and other strategic opportunities as needed 
• Provide oversight and lead late stage teams responsible for development plans, study protocols, amendments, ICFs,  IBs, INDs, annual reports, CSRs, regulatory response documents and other regulatory submissions or documents as appropriate
• Collaborate with pharmacovigilance in the analysis of clinical trial safety data.
• Collaborate closely with Clinical Operations and be accountable for clinical trial conduct and timelines for associated key deliverables.
• Lead the design and writing of clinical protocols and associated clinical documents contribute as an author with the writing of abstracts, posters and/or meeting presentations
• Keep up to date with compliance, SOPs and adhere to ICH, GCP, and relevant regulatory guidelines.
• Provide medical leadership for internal audits and r